Research & Development

yy影院|偷偷鲁在线2018完整版|久草在线免费观看视频|久久国产精品12天天色得得撸"优惠卡"成"糟心卡" 收钱后跑路这种事为啥禁不住?

發布時間︰

  劉徹點點頭道︰“朕也很驕傲,有時候我很希望據兒永遠只有八歲……”   “太多了……”曹襄面色慘白。yy影院|偷偷鲁在线2018完整版|久草在线免费观看视频|久久国产精品12   雲哲指指自己桌子邊上的一盞小銅鈴道︰“你剛剛進去,這個銅鈴就響個不停,紅英本來在我這里跟我說話,听到鈴鐺響了,才趕過去的。”天天色   “陛下啊……微臣是一時糊涂啊!”   “我這一生順利的超乎了我自己的想象,想要找敵人,敵人一定會在我沖鋒的路上……這不真實啊!”得得撸   “給阿嬌貴人吧。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo